Skye Bioscience Analyst Ratings
Cantor Fitzgerald Initiates Coverage On Skye Bioscience With Overweight Rating, Announces Price Target of $21
Skye Bioscience (SKYE.US) was first covered by Oppenheimer, which gave it an superior market rating, with a target price of $25.00.
Skye Bioscience Analyst Ratings
Oppenheimer Initiates Coverage On Skye Bioscience With Outperform Rating, Announces Price Target of $25
Skye Bioscience Analyst Ratings
Skye Bioscience Analyst Ratings
No Data